Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 20, 2024

Total Value ($000): $1,854,897 (100.0% shares, 0.0% debt)

Holdings (38)

VTI VANGUARD INDEX FDS 15.0%

Value ($000) $277,823 Shares 1,038,550 Est. Cost $267.51 Unrealized —

BN BROOKFIELD CORP 8.7%

Value ($000) $161,185 Shares 3,880,230 Est. Cost $22.16 Unrealized +24.4%

TEM TEMPUS AI INC 7.7%

Value ($000) $142,605 Shares 4,074,419 Est. Cost $30.66 Unrealized 0.0%

ASML ASML HOLDING N V 7.4%

Value ($000) $136,367 Shares 133,336 Est. Cost $654.82 Unrealized —

CRM SALESFORCE INC 6.7%

Value ($000) $123,449 Shares 480,160 Est. Cost $193.03 Unrealized +37.1%

EWTX EDGEWISE THERAPEUTICS INC 6.2%

Value ($000) $114,263 Shares 6,344,430 Est. Cost $17.44 Unrealized 0.0%

CORT CORCEPT THERAPEUTICS INC 4.2%

Value ($000) $78,345 Shares 2,411,362 Est. Cost $23.02 Unrealized +19.0%

PCVX VAXCYTE INC 3.9%

Value ($000) $71,735 Shares 950,000 Est. Cost $31.07 Unrealized +119.1%

INSM INSMED INC 2.9%

Value ($000) $53,600 Shares 800,000 Est. Cost $23.10 Unrealized +67.9%

MIRM MIRUM PHARMACEUTICALS INC 2.8%

Value ($000) $51,285 Shares 1,500,000 Est. Cost $12.27 Unrealized +113.7%

CRNX CRINETICS PHARMACEUTICALS IN 2.4%

Value ($000) $44,790 Shares 1,000,000 Est. Cost $19.36 Unrealized +138.5%

CABO CABLE ONE INC 2.3%

Value ($000) $41,915 Shares 118,403 Est. Cost $987.67 Unrealized -62.4%

BMRN BIOMARIN PHARMACEUTICAL INC 2.2%

Value ($000) $40,342 Shares 490,000 Est. Cost $84.22 Unrealized -1.2%

— MERUS N V 2.2%

Value ($000) $39,940 Shares 675,000 Est. Cost $59.17 Unrealized —

AAPL APPLE INC 2.1%

Value ($000) $38,535 Shares 182,960 Est. Cost $90.57 Unrealized +104.4%

BABA ALIBABA GROUP HLDG LTD 1.9%

Value ($000) $36,060 Shares 500,827 Est. Cost $165.09 Unrealized —

PHVS PHARVARIS N V 1.7%

Value ($000) $32,430 Shares 1,725,000 Est. Cost $15.26 Unrealized +33.3%

CLDX CELLDEX THERAPEUTICS INC NEW 1.7%

Value ($000) $31,459 Shares 850,000 Est. Cost $37.73 Unrealized 0.0%

FDMT 4D MOLECULAR THERAPEUTICS IN 1.6%

Value ($000) $29,386 Shares 1,400,000 Est. Cost $17.62 Unrealized +42.4%

— LANZATECH GLOBAL INC 1.6%

Value ($000) $29,257 Shares 15,814,845 Est. Cost $3.88 Unrealized —

ALNY ALNYLAM PHARMACEUTICALS INC 1.6%

Value ($000) $28,767 Shares 118,383 Est. Cost $160.04 Unrealized -1.4%

AVBP ARRIVENT BIOPHARMA INC 1.5%

Value ($000) $27,825 Shares 1,500,000 Est. Cost $19.51 Unrealized -8.6%

VRDN VIRIDIAN THERAPEUTICS INC 1.4%

Value ($000) $26,020 Shares 2,000,000 Est. Cost $16.89 Unrealized -18.0%

— CARGO THERAPEUTICS INC 1.4%

Value ($000) $25,352 Shares 1,544,000 Est. Cost $21.87 Unrealized —

FOLD AMICUS THERAPEUTICS INC 1.3%

Value ($000) $24,800 Shares 2,500,000 Est. Cost $12.83 Unrealized -20.0%

BAM BROOKFIELD ASSET MANAGMT LTD 1.3%

Value ($000) $23,865 Shares 627,207 Est. Cost $31.11 Unrealized +19.7%

RCKT ROCKET PHARMACEUTICALS INC 1.3%

Value ($000) $23,683 Shares 1,100,000 Est. Cost $28.09 Unrealized -18.2%

LXEO LEXEO THERAPEUTICS INC 1.3%

Value ($000) $23,266 Shares 1,450,500 Est. Cost $13.07 Unrealized +11.1%

— BLUEPRINT MEDICINES CORP 1.0%

Value ($000) $18,862 Shares 175,000 Est. Cost $59.75 Unrealized —

KYTX KYVERNA THERAPEUTICS INC 0.7%

Value ($000) $13,125 Shares 1,750,000 Est. Cost $20.30 Unrealized -24.7%

— MORPHIC HLDG INC 0.7%

Value ($000) $12,776 Shares 375,000 Est. Cost $34.07 Unrealized —

— VERVE THERAPEUTICS INC 0.6%

Value ($000) $11,712 Shares 2,400,000 Est. Cost $12.43 Unrealized —

MGX METAGENOMI INC 0.4%

Value ($000) $7,344 Shares 1,800,000 Est. Cost $11.34 Unrealized -39.4%

IOBT IO BIOTECH INC 0.3%

Value ($000) $5,182 Shares 4,429,449 Est. Cost $6.26 Unrealized -77.7%

ABCL ABCELLERA BIOLOGICS INC 0.2%

Value ($000) $3,336 Shares 1,126,915 Est. Cost $8.47 Unrealized -55.3%

MQ MARQETA INC 0.1%

Value ($000) $2,420 Shares 441,558 Est. Cost $22.37 Unrealized -75.4%

— GALECTO INC 0.1%

Value ($000) $1,184 Shares 2,497,791 Est. Cost $12.51 Unrealized —

SPRO SPERO THERAPEUTICS INC 0.0%

Value ($000) $610 Shares 468,902 Est. Cost $11.41 Unrealized -86.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	1,038,550	$277,823	15.0%	$267.51	—	TOTAL STK MKT	922908769
BN	BROOKFIELD CORP	3,880,230	$161,185	8.7%	$22.16	+24.4%	CL A LTD VT SH	11271J107
TEM	TEMPUS AI INC	4,074,419	$142,605	7.7%	$30.66	0.0%	CL A	88023B103
ASML	ASML HOLDING N V	133,336	$136,367	7.4%	$654.82	—	N Y REGISTRY SHS	N07059210
CRM	SALESFORCE INC	480,160	$123,449	6.7%	$193.03	+37.1%	COM	79466L302
EWTX	EDGEWISE THERAPEUTICS INC	6,344,430	$114,263	6.2%	$17.44	0.0%	COM	28036F105
CORT	CORCEPT THERAPEUTICS INC	2,411,362	$78,345	4.2%	$23.02	+19.0%	COM	218352102
PCVX	VAXCYTE INC	950,000	$71,735	3.9%	$31.07	+119.1%	COM	92243G108
INSM	INSMED INC	800,000	$53,600	2.9%	$23.10	+67.9%	COM PAR $.01	457669307
MIRM	MIRUM PHARMACEUTICALS INC	1,500,000	$51,285	2.8%	$12.27	+113.7%	COM	604749101
CRNX	CRINETICS PHARMACEUTICALS IN	1,000,000	$44,790	2.4%	$19.36	+138.5%	COM	22663K107
CABO	CABLE ONE INC	118,403	$41,915	2.3%	$987.67	-62.4%	COM	12685J105
BMRN	BIOMARIN PHARMACEUTICAL INC	490,000	$40,342	2.2%	$84.22	-1.2%	COM	09061G101
—	MERUS N V	675,000	$39,940	2.2%	$59.17	—	COM	N5749R100
AAPL	APPLE INC	182,960	$38,535	2.1%	$90.57	+104.4%	COM	037833100
BABA	ALIBABA GROUP HLDG LTD	500,827	$36,060	1.9%	$165.09	—	SPONSORED ADS	01609W102
PHVS	PHARVARIS N V	1,725,000	$32,430	1.7%	$15.26	+33.3%	COM	N69605108
CLDX	CELLDEX THERAPEUTICS INC NEW	850,000	$31,459	1.7%	$37.73	0.0%	COM NEW	15117B202
FDMT	4D MOLECULAR THERAPEUTICS IN	1,400,000	$29,386	1.6%	$17.62	+42.4%	COM	35104E100
—	LANZATECH GLOBAL INC	15,814,845	$29,257	1.6%	$3.88	—	COM	51655R101
ALNY	ALNYLAM PHARMACEUTICALS INC	118,383	$28,767	1.6%	$160.04	-1.4%	COM	02043Q107
AVBP	ARRIVENT BIOPHARMA INC	1,500,000	$27,825	1.5%	$19.51	-8.6%	COM	04272N102
VRDN	VIRIDIAN THERAPEUTICS INC	2,000,000	$26,020	1.4%	$16.89	-18.0%	COM	92790C104
—	CARGO THERAPEUTICS INC	1,544,000	$25,352	1.4%	$21.87	—	COM	14179K101
FOLD	AMICUS THERAPEUTICS INC	2,500,000	$24,800	1.3%	$12.83	-20.0%	COM	03152W109
BAM	BROOKFIELD ASSET MANAGMT LTD	627,207	$23,865	1.3%	$31.11	+19.7%	CL A LMT VTG SHS	113004105
RCKT	ROCKET PHARMACEUTICALS INC	1,100,000	$23,683	1.3%	$28.09	-18.2%	COM	77313F106
LXEO	LEXEO THERAPEUTICS INC	1,450,500	$23,266	1.3%	$13.07	+11.1%	COM	52886X107
—	BLUEPRINT MEDICINES CORP	175,000	$18,862	1.0%	$59.75	—	COM	09627Y109
KYTX	KYVERNA THERAPEUTICS INC	1,750,000	$13,125	0.7%	$20.30	-24.7%	COM	501976104
—	MORPHIC HLDG INC	375,000	$12,776	0.7%	$34.07	—	COM	61775R105
—	VERVE THERAPEUTICS INC	2,400,000	$11,712	0.6%	$12.43	—	COM	92539P101
MGX	METAGENOMI INC	1,800,000	$7,344	0.4%	$11.34	-39.4%	COM	59102M104
IOBT	IO BIOTECH INC	4,429,449	$5,182	0.3%	$6.26	-77.7%	COM	449778109
ABCL	ABCELLERA BIOLOGICS INC	1,126,915	$3,336	0.2%	$8.47	-55.3%	COM	00288U106
MQ	MARQETA INC	441,558	$2,420	0.1%	$22.37	-75.4%	CLASS A COM	57142B104
—	GALECTO INC	2,497,791	$1,184	0.1%	$12.51	—	COM	36322Q107
SPRO	SPERO THERAPEUTICS INC	468,902	$610	0.0%	$11.41	-86.8%	COM	84833T103